Search

everythinglearnresearchcommunity

for

Search:↓

Somatostatin analogues effectively manage ectopic ACTH syndrome when surgery isn't possible.

Steroid sulfatase inhibitors could potentially treat hormone-related disorders like certain cancers, hair loss, acne, and improve cognitive dysfunction.

Steroid sulfatase inhibitors could help treat hormone-related disorders and cancers.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Blocking Oncostatin M's role in the JAK-STAT pathway can stimulate hair growth in mice.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

Stilbamidine and hydroxystilbamidine inhibit enzyme release from lysosomes and have effects similar to cortisol and chloroquine.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

The new delivery system improved hair growth in alopecia treatment.

A substance called Compound 2g can strongly block STS (a hormone-related enzyme) without affecting estrogen levels, making it potentially good for treating breast cancer.

Megestrol acetate helps fat-derived stem cells grow, move, and turn into fat cells through a specific receptor.

Anabolic steroids boost muscle growth, SARMs increase muscle mass and bone density without side effects, and myostatin inhibitors block a protein that stops muscle growth, but each has potential risks.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Combining antidiabetic drugs, hormonal therapies, and lifestyle changes can improve health in women with PCOS.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Steroid sulfatase in hair follicles may be a target for treating hair loss.

Long-term minoxidil use can cause pseudoacromegaly, but stopping it improves symptoms.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.

In STSD patients, the body compensates for low androgen levels by increasing another enzyme's activity.

Strontium zinc silicate may help treat osteoporosis and muscle loss.

Beta-sitosterol and stigmasterol might help prevent hair loss by blocking a specific enzyme.